Long-term smoking causes nitroglycerin resistance in platelets by depletion of intraplatelet glutathione

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 11, 2001, Pages 1852-1856

  Haramaki, Nobuya ^a   Ikeda, Hisao ^a   Takajo, Yoshinori ^a   Katoh, Atsushi ^a   Kanaya, Seiji ^a   Shintani, Satoshi ^a   Haramaki, Reiko ^a   Murohara, Toyoaki ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CGMP; Glutathione; Nitroglycerin; Platelets; Smoking

Indexed keywords

ACETYLCYSTEINE; CHOLESTEROL; CYCLIC GMP; GLUTATHIONE; GLYCERYL TRINITRATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG RESISTANCE; HUMAN; MALE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DEPLETION; RABBIT; SMOKING; THROMBOCYTE; THROMBOCYTE AGGREGATION;

EID: 0035572870     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq1001.097021     Document Type: Article

References (34)

1. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications: Effect of timing, dosage, and infarct location
2. Nitrates in the treatment of congestive heart failure
3. N-acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin
4. Direct comparison of the effects of nitropmsside, SIN 1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity
5. The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders
6. Nitric oxide and nitrovasodilators: Similarities, differences and potential interactions
7. Dose-dependent effect of intravenous nitroglycerin on platelet aggregation, and correlation with plasma glyceryl dinitrate concentration in healthy men
8. Reversal of human platelet aggregation by low concentrations of nitroglycerin in vitro in normal subjects
9. Effects of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocardial infarction
10. Different effects of calcium antagonists, nitrates, and β-blockers on platelet function, possible importance for the treatment of unstable angina
11. The mystery of nitrate resistance
12. Nitrate resistance and tolerance: Potential limitations in the treatment of congestive heart failure
13. Inhibition by nitroprusside of platelet calcium mobilization: Evidence for reduced sensitivity to nitric oxide in essential hypertension
14. Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM
15. Nitrate resistance in platelets from patients with stable angina pectoris
16. Biotransformation of glyceryl trinitrate by blood platelet as compared to vascular smooth muscle
17. Evidence for the inhibitory role of guanosine 3′,5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators
18. Platelet cyclic GMP: A potentially useful indicator to evaluate the effects of nitroglycerin and nitrate tolerance
19. Glutathione-ascorbic acid antioxidant system in animals
20. Networking antioxidants in the isolated rat heart are selectively depleted by ischemia-reperfusion
21. Relation of cigarette smoking to myocardial infarction in young women
22. Platelet aggregation induced by ADP or epinephrine is enhanced in habitual smokers
23. Oxidants in cigarette smoke: Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite
24. Selective modification of glutathione metabolism
25. Xanthine oxidase mediates cyclic flow variations in a canine model of coronary arterial thrombosis
26. Liquid chromatographic determination of common water-soluble antioxidants in biological samples
27. Analysis of glutathione and glutathione disulfide in whole cells and mitochondria by postcolumn derivatization high-performance liquid chromatography with orthophthalaldehyde
28. Long-term smoking impairs platelet-derived nitric oxide release: Direct measurement with a nitric oxide-selective electrode
29. Sulfhydryl requirement for relaxation of vascular smooth muscle
30. Mechanism of tolerance development to organic nitrates
31. Nitrate tolerance: Effect of thiol supplementation during prolonged nitroglycerin infusion in an in vivo rat model
32. Reduced thiols and the effect of intravenous nitroglycerin on platelet aggregation
33. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrite, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates
34. Mechanisms for the pharmacologic interaction on organic nitrates with thiols: Existence of an extracellular pathway for the reversal of nitrate vascular tolerance of N-acetylcysteine